Immediate Impact

31 standout
Sub-graph 1 of 14

Citing Papers

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
2022 Standout
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 Standout
2 intermediate papers

Works of Nancy B. Itano being referenced

OUTCOME OF ISOLATED RENAL CELL CARCINOMA FOSSA RECURRENCE AFTER NEPHRECTOMY
2000

Author Peers

Author Last Decade Papers Cites
Nancy B. Itano 284 256 303 12 515
Lars Christian Horn 237 173 332 12 602
J Bellot 350 123 331 23 605
Antoine S. Abi-Aad 167 120 311 15 612
Jeff Brady 205 152 241 16 540
Ted O. Morgan 223 267 423 10 620
C. Eghazarian 107 65 407 21 477
John Rabets 172 129 518 16 594
Benjamin S. Abeshouse 383 127 127 13 558
Kostantinos E. Psihramis 145 56 340 17 467
Francisco Paulo da Fonseca 391 236 119 17 570

All Works

Loading papers...

Rankless by CCL
2026